1887

Abstract

We have applied the polymerase chain reaction (PCR) technique to analyse mutations in the thymidine kinase (TK) gene of varicella-zoster virus (VZV) associated with resistance to the 5-bromovinyl (BVaraU) and 5-propynyl (PYaraU) analogues of arabinofuranosyl deoxyuridine. The results from this study allow three clear conclusions to be drawn. Firstly, the technique clearly shows that populations of VZV derived from plaque purification were truly clonal only when the plaques were initiated from cell-free virus (representing a tiny fraction of infectious virus) and plaques initiated by infected cells contained a mixture of variants. Secondly, despite the background mutations caused by errors of the Taq DNA polymerase, mutations relevant to drug resistance can easily be distinguished. The BVaraU-resistant mutant, 7-1, contained an aspartic acid to asparagine mutation at residue 18 and a single base deletion (position 65298 of the VZV DNA sequence), resulting in a frameshift and premature termination of the polypeptide chain, was found in the BVaraU-resistant mutant YSR. PYaraU-resistant virus populations contained viruses with one or more of three independent mutations, i.e. single base substitutions resulting in mutations from leucine to proline at residue 92, histidine to arginine at residue 97 and a deletion of 20bp (residues 65135 to 65154). Finally, the technique has uncovered novel sites in the virus TK associated with drug resistance. We conclude that amplification using the PCR combined with cloning and sequencing is a relatively rapid method for identifying mutations in small virus populations even when they are not homogeneous.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-3-623
1991-03-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/3/JV0720030623.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-3-623&mimeType=html&fmt=ahah

References

  1. Biron K. K., Fyfe J. A., Noblin J. E., Elion G. B. 1982; Selection and preliminary characterisation of acyclovir-resistant mutants of varicella-zoster virus. American Journal of Medicine 73:383–386
    [Google Scholar]
  2. Coen D. M., Schaffer P. A. 1980; Two different loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proceedings of the National Academy of Sciences, U.S.A. 77:2265–2269
    [Google Scholar]
  3. Crumpacker C. S., Schnipper L. E., Marlowe S. I., Kowalsky P. N., Hershey B. J., Levin M. J. 1982; Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. New England Journal of Medicine 306:343–346
    [Google Scholar]
  4. Darby G., Field H. J., Salisbury S. A. 1981; Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir resistance. Nature, London 289:81–83
    [Google Scholar]
  5. Davison A. J., Scott J. E. 1986; The complete DNA sequence of varicella-zoster virus. Journal of General Virology 67:1759–1816
    [Google Scholar]
  6. De Clerq E. 1988; Recent advances in the search for selective antiviral agents. Advances In Drug Research 17:1–59
    [Google Scholar]
  7. Dobersen M. J., Jerkofsky M., Greer S. 1976; Enzymatic basis for the selective inhibition of varicella-zoster virus by 5-halogenated analogs of deoxycytidine. Journal of Virology 20:478–486
    [Google Scholar]
  8. Dunning A. M., Talmud P., Humphries S. E. 1988; Errors in the polymerase chain reaction. Nucleic Acids Research 16:10393
    [Google Scholar]
  9. Elion G. B., Furman P. A., Fyfe J. A., Miranda P. D., Beauchamp L., Schaeffer H. J. 1977; Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences, U.S.A. 74:5716–5720
    [Google Scholar]
  10. Erlich K. S., Mills J., Chatis P., Mertz G. J., Busch D. F., Follansbee S. E., Grant R. M., Crumpacker C. S. 1989; Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 320:293–296
    [Google Scholar]
  11. Honess R. W. 1981; Complementation between phosphonoacetic acid-resistant and -sensitive variants of herpes simplex viruses: evidence for an oligomeric protein with restricted intracellular diffusion as the determinant of resistance and sensitivity. Journal of General Virology 57:297–306
    [Google Scholar]
  12. Honess R. W., Craxton M. A., Williams L., Gompels U. A. 1989; A comparative analysis of the sequence of the thymidine kinase gene of a gammaherpesvirus, herpesvirus saimiri. Journal of General Virology 70:3003–3013
    [Google Scholar]
  13. Kaehler R., Strauss M., Kiessling U. 1984; A well transformable E. coli tdk strain suitable for direct rescue of tk gene plasmids from mammalian cells. Biomedica et biochimica acta 43:K25–K29
    [Google Scholar]
  14. Keohavong P., Thilly W. G. 1989; Fidelity of DNA polymerases in DNA amplification. Proceedings of the National Academy of Sciences, U.S.A 86:9253–9257
    [Google Scholar]
  15. Kit S. 1985; Thymidine kinase. Microbiological Sciences 2:369–375
    [Google Scholar]
  16. Lopetegui P., Matsunaga Y., Okuno T., Ogino T., Yamanishi K. 1983; Expression of varicella-zoster virus-related antigens in biochemically transformed cells. Journal of General Virology 64:1181–1186
    [Google Scholar]
  17. Machida H., Kuninaka A., Yoshino H. 1982; Inhibitory effects of anti-herpesviral thymidine analogs against varicella-zoster virus. Antimicrobial Agents and Chemotherapy 21:358–361
    [Google Scholar]
  18. Mori H., Shiraki K., Kato T., Hayakawa Y., Yamanishi K., Takahashi M. 1988; Molecular analysis of the thymidine kinase of thymidine kinase-deficient mutants of varicella-zoster virus. Intervirology 29:301–310
    [Google Scholar]
  19. Sakuma T. 1984; Strains of varicella-zoster virus resistant to 1 -β-d-arabinofuranosyl-E-5-(2-bromovinyl) uracil. Antimicrobial Agents and Chemotherapy 25:742–746
    [Google Scholar]
  20. Sanger F., Coulson A. R., Barrell B. G., Smith A. J. H., Roe B. A. 1980; Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. Journal of Molecular Biology 143:161–178
    [Google Scholar]
  21. Sawyer M. H., Inchauspe G., Biron K. K., Waters D. J., Straus S. E., Ostrove J. M. 1988; Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. Journal of General Virology 69:2585–2593
    [Google Scholar]
  22. Shiraki K., Ogino T., Yamanishi K., Takahashi M. 1986; Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus. Biken Journal 29:7–10
    [Google Scholar]
  23. Suzutani T., Machida H., Sakuma T. 1988; Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex type 1 in Vero and human embryo lung fibroblast cells. Antimicrobial Agents and Chemotherapy 32:1046–1052
    [Google Scholar]
  24. Tabor S., Richardson C. C. 1985; A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proceedings of the National Academy of Sciences, U.S.A. 82:1074–1078
    [Google Scholar]
  25. Tindall K. R., Kunkel T. A. 1988; Fidelity of synthesis by the Thermus aquaticus DNA polymerase. Biochemistry 27:6008–6013
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-3-623
Loading
/content/journal/jgv/10.1099/0022-1317-72-3-623
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error